Logo image of ALLIX.PA

WALLIX GROUP (ALLIX.PA) Stock Fundamental Analysis

EPA:ALLIX - Euronext Paris - Matif - FR0010131409 - Common Stock - Currency: EUR

22.8  -0.6 (-2.56%)

Fundamental Rating

2

Taking everything into account, ALLIX scores 2 out of 10 in our fundamental rating. ALLIX was compared to 103 industry peers in the Software industry. ALLIX has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, ALLIX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ALLIX has reported negative net income.
In the past year ALLIX had a positive cash flow from operations.
ALLIX had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: ALLIX reported negative operating cash flow in multiple years.
ALLIX.PA Yearly Net Income VS EBIT VS OCF VS FCFALLIX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

The Return On Assets of ALLIX (-7.92%) is worse than 72.82% of its industry peers.
ALLIX has a worse Return On Equity (-43.66%) than 80.58% of its industry peers.
Industry RankSector Rank
ROA -7.92%
ROE -43.66%
ROIC N/A
ROA(3y)-11.42%
ROA(5y)-10.74%
ROE(3y)-44.79%
ROE(5y)-35.26%
ROIC(3y)N/A
ROIC(5y)N/A
ALLIX.PA Yearly ROA, ROE, ROICALLIX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40 -50

1.3 Margins

The Gross Margin of ALLIX (113.33%) is better than 100.00% of its industry peers.
In the last couple of years the Gross Margin of ALLIX has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for ALLIX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 113.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.14%
GM growth 5Y-0.06%
ALLIX.PA Yearly Profit, Operating, Gross MarginsALLIX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100

More info and screens

1

2. Health

2.1 Basic Checks

ALLIX does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALLIX has a better debt/assets ratio than last year.
ALLIX.PA Yearly Shares OutstandingALLIX.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
ALLIX.PA Yearly Total Debt VS Total AssetsALLIX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of 1.08, we must say that ALLIX is in the distress zone and has some risk of bankruptcy.
ALLIX has a worse Altman-Z score (1.08) than 68.93% of its industry peers.
ALLIX has a Debt/Equity ratio of 0.81. This is a neutral value indicating ALLIX is somewhat dependend on debt financing.
ALLIX's Debt to Equity ratio of 0.81 is on the low side compared to the rest of the industry. ALLIX is outperformed by 73.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Altman-Z 1.08
ROIC/WACCN/A
WACC8.26%
ALLIX.PA Yearly LT Debt VS Equity VS FCFALLIX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

ALLIX has a Current Ratio of 0.88. This is a bad value and indicates that ALLIX is not financially healthy enough and could expect problems in meeting its short term obligations.
ALLIX has a Current ratio of 0.88. This is in the lower half of the industry: ALLIX underperforms 72.82% of its industry peers.
ALLIX has a Quick Ratio of 0.88. This is a bad value and indicates that ALLIX is not financially healthy enough and could expect problems in meeting its short term obligations.
ALLIX has a Quick ratio of 0.88. This is in the lower half of the industry: ALLIX underperforms 70.87% of its industry peers.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.88
ALLIX.PA Yearly Current Assets VS Current LiabilitesALLIX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

6

3. Growth

3.1 Past

ALLIX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 47.55%, which is quite impressive.
ALLIX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.96%.
ALLIX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.85% yearly.
EPS 1Y (TTM)47.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140.34%
Revenue 1Y (TTM)12.96%
Revenue growth 3Y13.73%
Revenue growth 5Y15.85%
Sales Q2Q%16.63%

3.2 Future

The Earnings Per Share is expected to grow by 57.88% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 22.44% on average over the next years. This is a very strong growth
EPS Next Y107.79%
EPS Next 2Y77.28%
EPS Next 3Y57.88%
EPS Next 5YN/A
Revenue Next Year21.88%
Revenue Next 2Y22.98%
Revenue Next 3Y22.44%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALLIX.PA Yearly Revenue VS EstimatesALLIX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ALLIX.PA Yearly EPS VS EstimatesALLIX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 -1 1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALLIX. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 368.93, the valuation of ALLIX can be described as expensive.
65.05% of the companies in the same industry are cheaper than ALLIX, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 36.28. ALLIX is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 368.93
ALLIX.PA Price Earnings VS Forward Price EarningsALLIX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALLIX.PA Per share dataALLIX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALLIX does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as ALLIX's earnings are expected to grow with 57.88% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y77.28%
EPS Next 3Y57.88%

More info and screens

0

5. Dividend

5.1 Amount

ALLIX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WALLIX GROUP

EPA:ALLIX (8/5/2025, 7:00:00 PM)

22.8

-0.6 (-2.56%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-17 2025-07-17
Earnings (Next)N/A N/A
Inst Owners11.9%
Inst Owner ChangeN/A
Ins Owners19.96%
Ins Owner ChangeN/A
Market Cap152.30M
Analysts84
Price Target19.38 (-15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)8.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 368.93
P/S 4.47
P/FCF N/A
P/OCF 98.26
P/B 15.49
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.68
EYN/A
EPS(NY)0.06
Fwd EY0.27%
FCF(TTM)-0.73
FCFYN/A
OCF(TTM)0.23
OCFY1.02%
SpS5.1
BVpS1.47
TBVpS-1.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.92%
ROE -43.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 113.33%
FCFM N/A
ROA(3y)-11.42%
ROA(5y)-10.74%
ROE(3y)-44.79%
ROE(5y)-35.26%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.14%
GM growth 5Y-0.06%
F-Score5
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 149.87%
Cap/Sales 18.87%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.88
Quick Ratio 0.88
Altman-Z 1.08
F-Score5
WACC8.26%
ROIC/WACCN/A
Cap/Depr(3y)134.63%
Cap/Depr(5y)153.59%
Cap/Sales(3y)19.11%
Cap/Sales(5y)22.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140.34%
EPS Next Y107.79%
EPS Next 2Y77.28%
EPS Next 3Y57.88%
EPS Next 5YN/A
Revenue 1Y (TTM)12.96%
Revenue growth 3Y13.73%
Revenue growth 5Y15.85%
Sales Q2Q%16.63%
Revenue Next Year21.88%
Revenue Next 2Y22.98%
Revenue Next 3Y22.44%
Revenue Next 5YN/A
EBIT growth 1Y40.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year70.43%
EBIT Next 3Y66%
EBIT Next 5YN/A
FCF growth 1Y40.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y144.57%
OCF growth 3Y-37.14%
OCF growth 5YN/A